Valora Therapeutics Inc.
PrivateLast Round
Seed
Nov 20, 2024
Total Funding Raised
$30M
Company Overview
Valora Therapeutics Inc. is a biotechnology company that develops novel biotherapeutic drug candidates for oncology and immune diseases using its proprietary AbLec glyco-immune checkpoint modulation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valora Therapeutics Inc. Comparables
Compare Valora Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GO Therapeutics | 83% | |
| Palleon Pharmaceuticals | 82% | |
| GlycoTherapeutics | 80% | |
Valora Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 20, 2024 |
Valora Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alexandria Venture Investments | Seed |
| Avalon BioVentures | Seed |
| Correlation Ventures | Seed |
| TigerGene | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 25, 2024
Grew 80% QoQ from 5 to 9 employees.
Valora Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Valora Therapeutics Inc.'s valuation, stock price, and market status.